Service evaluation of an integrated respiratory service in identifying and supporting patients with severe asthma on biologics (ID 560)
Respiratory department, Royal Derby Hospital, Derby, UK
Abstract
Introduction: Asthma biologics can be lifechanging for patients with severe asthma. Yet, identification of potential patients for treatment in primary-care is often deficient1.
Derbyshire has the highest population-adjusted uptake of biologics across the Midlands. Part of this success may be attributed to the Improving Adult respiratory Care Together (ImpACT+) team, an integrated care service providing holistic support for patients with lung diseases2. This includes virtual multidisciplinary team (MDT) discussion between primary-care teams and respiratory clinicians regarding complex cases.
We evaluated the role of ImpACT+ in identifying and supporting patients newly started on asthma biologics.
Methods: Data were retrospectively reviewed for patients on biologics at the Royal Derby Hospital between January 2018-2023. The number of ImpACT+ referrals, services accessed, and dates of biologic initiation were recorded. The time to starting treatment from ImpACT+ MDT discussion was compared against published national waiting times3. Data are presented as mean(SD), median(IQR), or n(%).
Results: 247 patients [age: 55(14) years, n male/female: 89/158] received biologics. There were 245 ImpACT+ referrals, with 124(50%) patients requiring at least one referral. Services accessed are outlined in Figure 1. 33 patients were discussed in the MDT (28 before biologics). The time to treatment was 439(325-627) days, which is shorter than previously published data (63.5 weeks from primary-care referral to starting biologics).
Conclusion: The ImpACT+ team enabled patients with asthma to access a range of specialist services prior to and following biologics initiation. Furthermore, referral to the ImpACT+ MDT facilitated access to severe asthma care and biologic pharmacotherapy.
Reference:
1. Management of Uncontrolled Asthma in Adults, 2022 (https://www.healthinnovationoxford.org/wp-content/uploads/2022/06/AAC-Pathway-16.9_FINAL-No-NHS.pdf)
2. Subramanian D, et al. P170 Reducing non-elective respiratory admissions: initial experience of the derby integrated ImpACT+ respiratory service.Thorax 2019;74:A182
3. Rupani H, et al. P145 What is the severe asthma patient journey to biologic initiation in UK severe asthma centres?Thorax 2022;77:A159-A160.
Funding: None
Conflicts of interest: None
The conference has been instigated and organised by PCRS. We are grateful to sponsors and exhibitors who have contributed funding towards this event in return for exhibition space. Neither sponsors or exhibitors have had any input into the agenda or the selection of speakers with the exception of any sponsored satellite symposia which are clearly indicated. View the full list of sponsors.